Citation Impact
Citing Papers
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults.
2006 Standout
Genetic variability: The key problem in the prevention and therapy of RNA‐based virus infections
2003
Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza
2001
Immunization of seronegative infants with hepatitis A vaccine (HAVRIX®; SKB): a comparative study of two dosing schedules
1997
Hepatitis C Virus Infection
2001 Standout
Safety and immunogenicity of hepatitis A vaccine in infants: a candidate for inclusion in the childhood vaccination programme
1999
Immunoprecipitation and Virus Neutralization Assays Demonstrate Qualitative Differences between Protective Antibody Responses to Inactivated Hepatitis A Vaccine and Passive Immunization with Immune Globulin
1997
Possible approaches to develop vaccines against hepatitis A
1992
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Sexual dimorphism of humoral immunity with human vaccines
2008
Does immunoglobulin interfere with the immunogenicity to Pasteur Mérieux inactivated hepatitis A vaccine?
1997
Long‐term immunogenicity of an inactivated virosome hepatitis A vaccine
2002
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
1999 Standout
Immunogenicity and protectivity of a new liposomal hepatitis A vaccine
1997
Long-term Durability of Immune Responses After Hepatitis A Vaccination Among HIV-Infected Adults
2011
Hepatitis B Vaccination in HIV-Infected Youth: A Randomized Trial of Three Regimens
2011
The annual impact of seasonal influenza in the US: Measuring disease burden and costs
2007 Standout
Interference assessment of yellow fever vaccine with the immune response to a single-dose inactivated hepatitis A vaccine (1440 EL.U.). A controlled study in adults
1996
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Epidemiology of hepatitis C
1997 Standout
Immunogenicity of Inactivated Hepatitis A Vaccine in Children With Chronic Liver Disease
2004
Immunoglobulin Prophylaxis for Hepatitis A
1992
Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease
1998
Long-term antibody persistence after vaccination with a 2-dose Havrix™ (inactivated hepatitis A vaccine): 20 years of observed data, and long-term model-based predictions
2015
Hepatitis A antibodies in liver transplant recipients: Evidence for loss of immunity posttransplantation
2000
A randomized, controlled study in adults of the immunogenicity of a novel hepatitis B vaccine containing MF59 adjuvant
1999
Vaccine adjuvants – understanding molecular mechanisms to improve vaccines
2014 StandoutNobel
Immunogenicity of an inactivated hepatitis A vaccine administered according to two different schedules and the interference of other “travellers” vaccines with the immune response
1996
The Xs and Y of immune responses to viral vaccines
2010
Clinical Experience With An Inactivated Hepatitis A Vaccine
1995
Chronic hepatitis B
2007 Standout
Cell mediated and antibody immune response to inactivated hepatitis A vaccine
2005
Chronic hepatitis B: Update 2009 #
2009 Standout
Vaccines to Prevent Viral Hepatitis
1997
Use and Safety of Acellular Pertussis Vaccine among Adult Hospital Staff during an Outbreak of Pertussis
1995
Natural or vaccine-induced antibody as a predictor of immunity in the face of natural challenge with influenza viruses
1989
Universal Mass Vaccination Against Hepatitis A
2006
SAFETY AND EFFICACY OF HEPATITIS A VACCINATION IN LIVER TRANSPLANTATION RECIPIENTS1, 2
2001
Vaccination greatly reduces disease, disability, death and inequity worldwide
2008 Standout
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
2014 Standout
The expanding universe of T-cell subsets: Th1, Th2 and more
1996 Standout
Immunogenicity of a combined hepatitis A and B vaccine in healthy young adults
2000
A Novel, Recombinant Triple Antigen Hepatitis B Vaccine (Hepacare<sup>®</sup>)
2001
Sex differences in immune responses
2016 Standout
Immunogenicity of an inactivated hepatitis A vaccine after exposure at 37°C for 1 week
1994
Liposomes as nanomedical devices
2015 Standout
Changing Epidemiology of Pertussis in the United States: Increasing Reported Incidence Among Adolescents and Adults, 1990‐1996
1999
Effect of postexposure vaccination in a chimpanzee model of hepatitis A virus infection
1994
Long-term protective effects of hepatitis A vaccines. A systematic review
2012
Reactogenicity and immunogenicity of a booster dose of a combined diphtheria, tetanus, and tricomponent acellular pertussis vaccine at fourteen to twenty-eight months of age
1997
Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A.
1992
Control of Hepatitis A Through Routine Vaccination of Children
2001
Efficacy of Virosome Hepatitis A Vaccine in Young Children in Nicaragua: Randomized Placebo‐Controlled Trial
2003
Simultaneous active and passive immunization against hepatitis A studied in a population of travellers
1993
Immunogenicity and safety in adults of hepatitis A virus vaccine administered as a single dose with a booster 6 months later
1994
A prospective, randomized, comparative US trial of a combination hepatitis A and B vaccine (Twinrix®) with corresponding monovalent vaccines (Havrix® and Engerix-B®) in adults
2001
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020
2020
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent acellular pertussis vaccine
1996
Novel Perspectives on the Hepatitis B Virus Vaccine in the Chronic Kidney Disease Population
2015
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Adult Immunization With Acellular Pertussis Vaccine
1993
Liposomal Formulations in Clinical Use: An Updated Review
2017 Standout
Vaccinating HIV patients: focus on human papillomavirus and herpes zoster vaccines.
2013 StandoutNobel
Prevention of Hepatitis A Through Active or Passive Immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
1999 Standout
Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
2003 Standout
Hepatitis C virus polyprotein vaccine formulations capable of inducing broad antibody and cellular immune responses
2006 StandoutNobel
Systematic review and economic decision modelling for the prevention and treatment of influenza A and B
2003
A Single Nucleotide Change in the 5′ Noncoding Region of Sindbis Virus Confers Neurovirulence in Rats
1999 StandoutNobel
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model
1993
The Roles of Vaccination and Amantadine Prophylaxis in Controlling an Outbreak of Influenza A (H3N2) in a Nursing Home
1988
Guidelines for Preventing Health-Care-Associated Pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee
2004 Standout
Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due toBordetella pertussisand OtherBordetellaSubspecies
2005 Standout
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Protection against hepatitis A by an inactivated vaccine.
1994
Diagnosis and Monitoring of Hepatic Injury. I. Performance Characteristics of Laboratory Tests
2000
Attenuated hepatitis A virus: genetic determinants of adaptation to growth in MRC-5 cells
1994
Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment
2017 StandoutNobel
Correlates of Protection Induced by Vaccination
2010 Standout
Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
2001 Standout
Works of A. Delem being referenced
Simultaneous vaccination against hepatitis A and B: results of a controlled study
1992
Hepatitis B vaccine containing surface antigen and selected preS1 and preS2 sequences. 1. Safety and immunogenicity in young, healthy adults
1997
Effect of virus strain and antigen dose on immunogenicity and reactogenicity of an inactivated hepatitis A vaccine
1992
Persistence of vaccine-induced antibody to hepatitis A virus
1992
Safety and immunogenicity of an inactivated hepatitis A candidate vaccine in healthy adult volunteers
1990
Hepatitis B vaccine containing surface antigen and selected preS1 and preS2 sequences 2. Immunogenicity in poor responders to hepatitis B vaccines
1997
Clinical and immunological investigation of a new combined hepatitis A and hepatitis B vaccine
1994
Development of an acellular pertussis vaccine and its administration as a booster in healthy adults
1991
Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine: rationale and summary of findings
1992
Characterization of the immune response of volunteers vaccinated with a killed vaccine against hepatitis A
1993
Placebo-controlled efficacy study of hepatitis A vaccine in Valdivia, Chile
1992
Comparison of modified HAVAB and ELISA for determination of vaccine-induced anti-HAV response
1992
Immunization Of Us Soldiers With A Two-Dose Primary Series Of Inactivated Hepatitis A Vaccine: Early Immune Response, Persistence Of Antibody, And Response To A Third Dose At 1 Year
1995
Inactivated hepatitis A vaccine: long-term antibody persistence
1997
Serum SRH antibody level as a measure of the immunity against natural and artificial A/Victoria/3/75 infections.
1978
Correlation between Rate of Infection and Preexisting Titer of Serum Antibody as Determined by Single Radial Hemolysis during an Epidemic of Influenza A/Victoria/3/75
1978